DexCom, Inc. (DXCM)
69.54
+0.30
(+0.43%)
USD |
NASDAQ |
Jan 16, 16:00
68.53
-1.01
(-1.45%)
After-Hours: 04:21
DexCom EPS Diluted (Quarterly): 0.7035 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| BioLife Solutions, Inc. | 0.0127 |
| Boston Scientific Corp. | 0.5048 |
| Krystal Biotech, Inc. | 2.660 |
| Tandem Diabetes Care, Inc. | -0.3128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 283.80M |
| Revenue (Quarterly) | 1.209B |
| Total Expenses (Quarterly) | 925.50M |
| Enterprise Value | 26.38B |
| Gross Profit Margin (Quarterly) | 61.80% |
| Profit Margin (Quarterly) | 23.47% |
| Earnings Yield | 2.58% |
| Operating Earnings Yield | 2.74% |
| Normalized Earnings Yield | 2.584 |